Literature DB >> 23149888

The clinical evaluation of novel imaging methods for cancer management.

Lalitha K Shankar1.   

Abstract

The National Cancer Institute (NCI) has a long-standing interest in evaluating and using the known advantages of molecular and functional imaging, as well as assessing the potential of novel imaging agents and modalities, to improve clinical cancer research and cancer care. In this Perspectives article, I discuss the strategies and resources being used by the NCI to foster and enhance these evaluations. Although resource and logistical challenges abound in successfully mounting these trials, many examples exist of real and potential solutions to improve the clinical evaluation process for imaging agents and modalities in the USA and in international collaborations.

Entities:  

Mesh：

Year:  2012        PMID： 23149888     DOI： 10.1038/nrclinonc.2012.186

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


  26 in total

1.  Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.

Authors:  Tracy T Batchelor; Dan G Duda; Emmanuelle di Tomaso; Marek Ancukiewicz; Scott R Plotkin; Elizabeth Gerstner; April F Eichler; Jan Drappatz; Fred H Hochberg; Thomas Benner; David N Louis; Kenneth S Cohen; Houng Chea; Alexis Exarhopoulos; Jay S Loeffler; Marsha A Moses; Percy Ivy; A Gregory Sorensen; Patrick Y Wen; Rakesh K Jain
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

Review 2.  Considerations for the use of imaging tools for phase II treatment trials in oncology.

Authors:  Lalitha K Shankar; Annick Van den Abbeele; Jeff Yap; Robert Benjamin; Scott Scheutze; T J Fitzgerald
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

3.  Imaging biomarkers, an industry perspective.

Authors:  Adrian Nunn
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

4.  Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.

Authors:  Csaba Juhász; Zeina Nahleh; Ian Zitron; Diane C Chugani; Majid Z Janabi; Sudeshna Bandyopadhyay; Rouba Ali-Fehmi; Thomas J Mangner; Pulak K Chakraborty; Sandeep Mittal; Otto Muzik
Journal:  Nucl Med Biol       Date:  2012-03-22       Impact factor: 2.408

5.  Mapping sensorimotor cortex with slow cortical potential resting-state networks while awake and under anesthesia.

Authors:  Jonathan D Breshears; Charles M Gaona; Jarod L Roland; Mohit Sharma; David T Bundy; Joshua S Shimony; Samiya Rashid; Lawrence N Eisenman; R Edward Hogan; Abraham Z Snyder; Eric C Leuthardt
Journal:  Neurosurgery       Date:  2012-08       Impact factor: 4.654

6.  Validation of novel imaging methodologies for use as cancer clinical trial end-points.

Authors:  D J Sargent; L Rubinstein; L Schwartz; J E Dancey; C Gatsonis; L E Dodd; L K Shankar
Journal:  Eur J Cancer       Date:  2008-12-16       Impact factor: 9.162

7.  Lessons learned from independent central review.

Authors:  R Ford; L Schwartz; J Dancey; L E Dodd; E A Eisenhauer; S Gwyther; L Rubinstein; D Sargent; L Shankar; P Therasse; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

8.  NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies.

Authors:  Alexander M Spence; Mark Muzi; Jeanne M Link; Finbarr O'Sullivan; Janet F Eary; John M Hoffman; Lalitha K Shankar; Kenneth A Krohn
Journal:  Mol Imaging Biol       Date:  2009-03-27       Impact factor: 3.488

9.  NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.

Authors:  Alexander M Spence; Mark Muzi; Jeanne M Link; John M Hoffman; Janet F Eary; Kenneth A Krohn
Journal:  Mol Imaging Biol       Date:  2008-06-10       Impact factor: 3.488

10.  Topical polyethylene glycol as a novel chemopreventive agent for oral cancer via targeting of epidermal growth factor response.

Authors:  Ramesh K Wali; Dhananjay P Kunte; Mart De La Cruz; Ashish K Tiwari; Jeffrey Brasky; Christopher R Weber; Tina P Gibson; Amir Patel; Suzana D Savkovic; Bruce E Brockstein; Hemant K Roy
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240
View more
  7 in total

Review 1.  Non-FDG PET/CT in Diagnostic Oncology: a pictorial review.

Authors:  Francesco Giammarile; Paolo Castellucci; Rudi Dierckx; Enrique Estrada Lobato; Mohsen Farsad; Roland Hustinx; Amirreza Jalilian; Olivier Pellet; Susana Rossi; Diana Paez
Journal:  Eur J Hybrid Imaging       Date:  2019-11-29

2.  Performance Observations of Scanner Qualification of NCI-Designated Cancer Centers: Results From the Centers of Quantitative Imaging Excellence (CQIE) Program.

Authors:  Mark Rosen; Paul E Kinahan; James F Gimpel; Adam Opanowski; Barry A Siegel; G Craig Hill; Linda Weiss; Lalitha Shankar
Journal:  Acad Radiol       Date:  2016-11-29       Impact factor: 3.173

3.  Triply Loaded Nitroxide Brush-Arm Star Polymers Enable Metal-Free Millimetric Tumor Detection by Magnetic Resonance Imaging.

Authors:  Hung V-T Nguyen; Alexandre Detappe; Nolan M Gallagher; Hui Zhang; Peter Harvey; Changcun Yan; Clelia Mathieu; Matthew R Golder; Yivan Jiang; Maria Francesca Ottaviani; Alan Jasanoff; Andrzej Rajca; Irene Ghobrial; P Peter Ghoroghchian; Jeremiah A Johnson
Journal:  ACS Nano       Date:  2018-11-02       Impact factor: 15.881

Review 4.  Imaging biomarker roadmap for cancer studies.

Authors:  James P B O'Connor; Eric O Aboagye; Judith E Adams; Hugo J W L Aerts; Sally F Barrington; Ambros J Beer; Ronald Boellaard; Sarah E Bohndiek; Michael Brady; Gina Brown; David L Buckley; Thomas L Chenevert; Laurence P Clarke; Sandra Collette; Gary J Cook; Nandita M deSouza; John C Dickson; Caroline Dive; Jeffrey L Evelhoch; Corinne Faivre-Finn; Ferdia A Gallagher; Fiona J Gilbert; Robert J Gillies; Vicky Goh; John R Griffiths; Ashley M Groves; Steve Halligan; Adrian L Harris; David J Hawkes; Otto S Hoekstra; Erich P Huang; Brian F Hutton; Edward F Jackson; Gordon C Jayson; Andrew Jones; Dow-Mu Koh; Denis Lacombe; Philippe Lambin; Nathalie Lassau; Martin O Leach; Ting-Yim Lee; Edward L Leen; Jason S Lewis; Yan Liu; Mark F Lythgoe; Prakash Manoharan; Ross J Maxwell; Kenneth A Miles; Bruno Morgan; Steve Morris; Tony Ng; Anwar R Padhani; Geoff J M Parker; Mike Partridge; Arvind P Pathak; Andrew C Peet; Shonit Punwani; Andrew R Reynolds; Simon P Robinson; Lalitha K Shankar; Ricky A Sharma; Dmitry Soloviev; Sigrid Stroobants; Daniel C Sullivan; Stuart A Taylor; Paul S Tofts; Gillian M Tozer; Marcel van Herk; Simon Walker-Samuel; James Wason; Kaye J Williams; Paul Workman; Thomas E Yankeelov; Kevin M Brindle; Lisa M McShane; Alan Jackson; John C Waterton
Journal:  Nat Rev Clin Oncol       Date:  2016-10-11       Impact factor: 66.675

Review 5.  Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology.

Authors:  John Kurhanewicz; Daniel B Vigneron; Jan Henrik Ardenkjaer-Larsen; James A Bankson; Kevin Brindle; Charles H Cunningham; Ferdia A Gallagher; Kayvan R Keshari; Andreas Kjaer; Christoffer Laustsen; David A Mankoff; Matthew E Merritt; Sarah J Nelson; John M Pauly; Philips Lee; Sabrina Ronen; Damian J Tyler; Sunder S Rajan; Daniel M Spielman; Lawrence Wald; Xiaoliang Zhang; Craig R Malloy; Rahim Rizi
Journal:  Neoplasia       Date:  2018-11-23       Impact factor: 5.715

6.  Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones).

Authors:  Leonard Howard Damelin; Rupal Jivan; Robin Bruce Veale; Amanda Louise Rousseau; Demetra Mavri-Damelin
Journal:  BMC Cancer       Date:  2014-05-05       Impact factor: 4.430

7.  Quantitative Imaging Informatics for Cancer Research.

Authors:  Andrey Fedorov; Reinhard Beichel; Jayashree Kalpathy-Cramer; David Clunie; Michael Onken; Jörg Riesmeier; Christian Herz; Christian Bauer; Andrew Beers; Jean-Christophe Fillion-Robin; Andras Lasso; Csaba Pinter; Steve Pieper; Marco Nolden; Klaus Maier-Hein; Markus D Herrmann; Joel Saltz; Fred Prior; Fiona Fennessy; John Buatti; Ron Kikinis
Journal:  JCO Clin Cancer Inform       Date:  2020-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.